Mainz Biomed Bv Stock Today
| MYNZ Stock | USD 0.87 0.04 4.40% |
Performance0 of 100
| Odds Of DistressOver 85
|
Mainz Biomed is trading at 0.87 as of the 23rd of April 2024; that is -4.4 percent decrease since the beginning of the trading day. The stock's open price was 0.91. Mainz Biomed has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Mainz Biomed BV are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of March 2024 and ending today, the 23rd of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 5th of November 2021 | Category Healthcare | Classification Health Care |
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic and research use only tests for clinical diagnostics in human genetics. The company was founded in 2008 and is based in Mainz, Germany. Mainz Biomed is traded on NASDAQ Exchange in the United States.. The company has 21.89 M outstanding shares of which 307.28 K shares are now shorted by private and institutional investors with about 4.27 trading days to cover. More on Mainz Biomed BV
Follow Valuation Profit Patterns Odds of Bankruptcy
Financial Report 21st of May 2024
Mainz Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Mainz Biomed's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Mainz Biomed or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Mainz Biomed report their recommendations after researching Mainz Biomed's financial statements, talking to executives and customers, or listening in on Mainz Biomed's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Mainz Biomed BV. The Mainz consensus assessment is calculated by taking the average forecast from all of the analysts covering Mainz Biomed. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the measurements of operating efficiency obtained from Mainz Biomed's historical financial statements, Mainz Biomed BV is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Mainz Biomed BV is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mainz Biomed's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Mainz Biomed's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Mainz Biomed's financial leverage. It provides some insight into what part of Mainz Biomed's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mainz Biomed BV (MYNZ) is traded on NASDAQ Exchange in USA. It is located in Robert Koch Strasse 50, Mainz, Germany, 55129 and employs 65 people. Mainz Biomed is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 19.81 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mainz Biomed's market, we take the total number of its shares issued and multiply it by Mainz Biomed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Mainz Biomed BV conducts business under Biotechnology sector and is part of Health Care industry. The entity has 21.89 M outstanding shares of which 307.28 K shares are now shorted by private and institutional investors with about 4.27 trading days to cover.
Mainz Biomed BV currently holds about 26.01 M in cash with (21.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.8, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Mainz Biomed Probability Of Bankruptcy
Ownership AllocationMainz Biomed BV holds a total of 21.89 Million outstanding shares. Mainz Biomed BV secures 16.58 % of its outstanding shares held by insiders and 1.0 % owned by institutional investors. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Mainz Ownership Details
Mainz Stock Price Odds Analysis
Based on a normal probability distribution, the odds of Mainz Biomed jumping above the current price in 90 days from now is about 98.0%. The Mainz Biomed BV probability density function shows the probability of Mainz Biomed stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Mainz Biomed BV has a beta of -0.1139. This indicates as returns on the benchmark increase, returns on holding Mainz Biomed are expected to decrease at a much lower rate. During a bear market, however, Mainz Biomed BV is likely to outperform the market. Additionally, mainz Biomed BV has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Mainz Biomed to move above the current price in 90 days from now is about 98.0 (This Mainz Biomed BV probability density function shows the probability of Mainz Stock to fall within a particular range of prices over 90 days) .
Mainz Biomed Historical Income Statement
Mainz Biomed BV Income Statement is one of the three primary financial statements used for reporting Mainz's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Mainz Biomed BV revenue and expense. Mainz Biomed Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Mainz Biomed's Depreciation And Amortization is fairly stable compared to the past year. Gross Profit is likely to rise to about 535.1 K in 2024, despite the fact that Net Interest Income is likely to grow to (769.1 K). View More FundamentalsMainz Stock Against Markets
Picking the right benchmark for Mainz Biomed stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Mainz Biomed stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Mainz Biomed is critical whether you are bullish or bearish towards Mainz Biomed BV at a given time. Please also check how Mainz Biomed's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Mainz Biomed without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| All Next | Launch Module |
Mainz Biomed Corporate Management
Elected by the shareholders, the Mainz Biomed's board of directors comprises two types of representatives: Mainz Biomed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mainz. The board's role is to monitor Mainz Biomed's management team and ensure that shareholders' interests are well served. Mainz Biomed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mainz Biomed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Corinna Gorges | Head RD | Profile | |
| Chris PMP | Chief Officer | Profile | |
| Frank KriegSchneider | Chief Officer | Profile | |
| Darin Leigh | Chief Officer | Profile | |
| Philipp Freese | Chief Officer | Profile | |
| Petra Ploesser | Head Quality | Profile | |
| Guido Baechler | CEO Director | Profile |
How to buy Mainz Stock?
Before investing in Mainz Biomed, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Mainz Biomed. To buy Mainz Biomed stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Mainz Biomed. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Mainz Biomed stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Mainz Biomed BV stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Mainz Biomed BV stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Mainz Biomed BV, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Mainz Stock please use our How to Invest in Mainz Biomed guide.
Already Invested in Mainz Biomed BV?
The danger of trading Mainz Biomed BV is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Mainz Biomed is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Mainz Biomed. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Mainz Biomed BV is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Mainz Biomed BV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mainz Biomed's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mainz Biomed Bv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mainz Biomed Bv Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mainz Biomed BV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Mainz Stock analysis
When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stocks Directory Find actively traded stocks across global markets |
Is Mainz Biomed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mainz Biomed. If investors know Mainz will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mainz Biomed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.62) | Revenue Per Share 0.055 | Quarterly Revenue Growth 0.111 | Return On Assets (0.93) | Return On Equity (3.03) |
The market value of Mainz Biomed BV is measured differently than its book value, which is the value of Mainz that is recorded on the company's balance sheet. Investors also form their own opinion of Mainz Biomed's value that differs from its market value or its book value, called intrinsic value, which is Mainz Biomed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mainz Biomed's market value can be influenced by many factors that don't directly affect Mainz Biomed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mainz Biomed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mainz Biomed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mainz Biomed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.